# Study of Etoposide in Breast Cancer Patients

> **NCT00026949** · — · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 33 (—)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00026949
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1999-08
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** 33 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00026949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00026949, "Study of Etoposide in Breast Cancer Patients". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00026949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*